Skip to main content
Toggle navigation
Login
Search
Home
Icon Legend
This session is not in your Favorites.
This session is in your Favorites. Click again to remove it.
Presentation Icons
ACG Award Winner
ACG Newsworthy Abstract
Registration Required
No CME
On-Demand Video
Livestream
Back
Favorite
Post (Tweet)
Yuki Otani (he/him/his)
Eli Lilly and Company
Poster(s):
P4371 - Mirikizumab Pharmacokinetics and Exposure-Response Relationships in Patients With Moderately to Severely Active Crohn’s Disease in Phase 2 and 3 Studies
Tuesday, October 29, 2024
10:30 AM – 4:00 PM
ET